SCHEMBL3485224

SCHEMBL3485224

COC(=O)c1ccc(CCC(C(=O)O)C(=O)O)cc1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP4A11 Q02928 2/20 0.60
CYP4F2 P78329 1/20 0.58
LOXL2 Q9Y4K0 1/20 0.56
TSHR P16473 1/20 0.50
ALDH1A1 P00352 1/20 0.50
TP53 P04637 1/20 0.50
CYP1A2 P05177 1/20 0.50
CYP3A4 P08684 1/20 0.50
CYP2C9 P11712 1/20 0.50
HPGD P15428 1/20 0.50
ALOX15 P16050 1/20 0.50
ALOX12 P18054 1/20 0.50
CYP2C19 P33261 1/20 0.50
CKS1B P61024 1/20 0.50
SKP2 Q13309 1/20 0.50
HIF1A Q16665 1/20 0.50
HSD17B10 Q99714 1/20 0.50
MGLL Q99685 1/20 0.50
ERAP2 Q6P179 1/20 0.49
LNPEP Q9UIQ6 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2160659 0.88 CYP4A11 (0.58) CYP4A11CYP4F2LOXL2TSHRALDH1A1
SCHEMBL7511335 0.87 CYP4A11 (0.57) CYP4A11CYP4F2LOXL2TSHRALDH1A1
SCHEMBL6656906 0.84 CYP4A11 (0.62) CYP4A11CYP4F2LOXL2ALDH1A1TP53
SCHEMBL8293519 0.84 CYP4A11 (0.62) CYP4A11CYP4F2LOXL2TSHRALDH1A1
SCHEMBL2490447 0.84 CYP4A11 (0.54) CYP4A11CYP4F2LOXL2TSHRALDH1A1
SCHEMBL70185 0.83 CYP4A11 (0.75) CYP4A11CYP4F2LOXL2TSHRALDH1A1
SCHEMBL29055656 0.83 CYP4A11 (0.60) CYP4A11CYP4F2LOXL2ALDH1A1TP53
SCHEMBL31753280 0.83 CYP4A11 (0.60) CYP4A11CYP4F2LOXL2TSHRALDH1A1
SCHEMBL2692900 0.82 LDHA (0.62) CYP4A11CYP4F2LOXL2TSHRMAPT
SCHEMBL10565182 0.81 LOXL2 (0.59) CYP4A11CYP4F2LOXL2ALDH1A1TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8609727-B2 Dicarboxylic acid derivatives and their use BAYER INTELLECTUAL PROPERTY GMBH (DE) 2013-12-17 US disclosed
US-20100029772-A1 Dicarboxylic Acid Derivatives and their Use BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2010-02-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100029772-A1 Dicarboxylic Acid Derivatives and their Use PC, SLC25A1, GOT2 CYP4A11 1566/4885CYP4F2 672/4885LOXL2 2783/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.